New Research Demonstrates 2.3 Point Reduction in HbA1c for Dario Digital Health Users with Baseline HbA1c Greater Than 9 points

Stock Information for DarioHealth Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DarioHealth Corp.

DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.